In contrast to previous studies demonstrating that Alzheimer's disease-linked substitutions in PS1 or PS2 have enhanced apoptotic activity, all the Alzheimer's disease-linked mutations that we tested have reduced apoptotic activity compared with wild-type, and thus may represent partial loss-of-function mutations.
